2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 4 filers reported holding 2SEVENTY BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,028 | -73.9% | 27,048 | -32.7% | 0.00% | – |
| Q2 2023 | $406,490 | +110.1% | 40,167 | +111.8% | 0.00% | – |
| Q1 2023 | $193,474 | +46.1% | 18,968 | +34.2% | 0.00% | – |
| Q4 2022 | $132,426 | -32.4% | 14,133 | +4.8% | 0.00% | – |
| Q3 2022 | $196,000 | -34.9% | 13,492 | -40.9% | 0.00% | – |
| Q2 2022 | $301,000 | -17.1% | 22,820 | +7.4% | 0.00% | – |
| Q1 2022 | $363,000 | -23.4% | 21,254 | +14.8% | 0.00% | – |
| Q4 2021 | $474,000 | – | 18,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,738,972 | $38,137,514 | 4.92% |
| Newtyn Management, LLC | 1,505,000 | $15,351,000 | 3.02% |
| CHI Advisors LLC | 855,000 | $8,721,000 | 2.32% |
| AlphaCentric Advisors LLC | 302,500 | $3,085,500 | 2.13% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $14,371 | 1.80% |
| Casdin Capital, LLC | 2,023,913 | $20,643,913 | 1.70% |
| Saturn V Capital Management LP | 172,188 | $1,756,318 | 1.31% |
| Iron Triangle Partners LP | 868,939 | $8,863,178 | 1.28% |
| SECTORAL ASSET MANAGEMENT INC | 476,000 | $4,855,200 | 0.93% |
| Lion Point Capital, LP | 170,000 | $1,734,000 | 0.71% |